Pharos 2023: an integrated resource for the understudied human proteome

Author:

Kelleher Keith J1ORCID,Sheils Timothy K1ORCID,Mathias Stephen L2ORCID,Yang Jeremy J2ORCID,Metzger Vincent T2ORCID,Siramshetty Vishal B1ORCID,Nguyen Dac-Trung1ORCID,Jensen Lars Juhl3ORCID,Vidović Dušica45ORCID,Schürer Stephan C456ORCID,Holmes Jayme2ORCID,Sharma Karlie R1ORCID,Pillai Ajay1ORCID,Bologa Cristian G2ORCID,Edwards Jeremy S27ORCID,Mathé Ewy A1ORCID,Oprea Tudor I2ORCID

Affiliation:

1. National Center for Advancing Translational Science , 9800 Medical Center Drive , Rockville , MD  20850, USA

2. Translational Informatics Division, Department of Internal Medicine, University of New Mexico Health Sciences Center , Albuquerque , NM  87131, USA

3. Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen   2200 , Copenhagen , Denmark

4. Institute for Data Science and Computing, University of Miami , Coral Gables , FL  33146, USA

5. Department of Molecular and Cellular Pharmacology, Miller School of Medicine, University of Miami , Miami , FL  33136, USA

6. Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami , Miami , FL  33136, USA

7. Department of Chemistry and Chemical Biology, University of New Mexico , Albuquerque , NM  87131, USA

Abstract

AbstractThe Illuminating the Druggable Genome (IDG) project aims to improve our understanding of understudied proteins and our ability to study them in the context of disease biology by perturbing them with small molecules, biologics, or other therapeutic modalities. Two main products from the IDG effort are the Target Central Resource Database (TCRD) (http://juniper.health.unm.edu/tcrd/), which curates and aggregates information, and Pharos (https://pharos.nih.gov/), a web interface for users to extract and visualize data from TCRD. Since the 2021 release, TCRD/Pharos has focused on developing visualization and analysis tools that help reveal higher-level patterns in the underlying data. The current iterations of TCRD and Pharos enable users to perform enrichment calculations based on subsets of targets, diseases, or ligands and to create interactive heat maps and UpSet charts of many types of annotations. Using several examples, we show how to address disease biology and drug discovery questions through enrichment calculations and UpSet charts.

Funder

National Institutes of Health

Novo Nordisk Foundation

Intramural Research Program, NCATS

Intramural/Extramural research program of the NCATS, NIH: Knowledge Management Center for Illuminating the Druggable Genome

Publisher

Oxford University Press (OUP)

Subject

Genetics

Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3